Novel Molecular Targets of Dezocine and Their Clinical Implications
Xi‐Ping Huang, Xi, Jin, Alexei Yeliseev, Bryan L. Roth, Renyu Liu · Carolina Digital Repository (University of North Carolina at Chapel Hill) · 2020
While dezocine is a partial mu opioid receptor agonist, it is not a controlled substance. Thus, the characterization of the molecular targets of dezocine is critical for scientific and clinical implications. The goal of this study is to characterize molecular targets for dezocine and their implications.